{"nct_id":"NCT02501629","title":"An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2015-09-29","start_date_type":"ACTUAL","primary_completion_date":"2017-06-19","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}